Evolent Health Inc. (EVH)$3.95
Currency: USD
Research Snapshot
Static fundamentals, valuation context, and investor signals for Evolent Health Inc. (EVH).
DCF ready
Valuation
7.7x
EV/FCF, 13.0% FCF yield
Quality
-139.5%
ROIC, 2.1% FCF margin
Growth
15.2%
5Y sales (revenue) CAGR
Balance sheet
0.0x
Debt/equity, 1.3x current ratio
Superinvestors
2
Top: Glenn Welling (4.2%)
Strengths to research
- Revenue compounded at 15.2% over five years.
- Debt/equity looks manageable at 0.0x.
- 10 annual periods are available for trend analysis.
Watchouts
No major valuation, balance sheet, or growth watchouts were detected by the static screen.
Annual data: 10 periods
Quarterly data: 24 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for EVH.
Grade D
29
/ 100
Financial Charts
No financial data available for EVH (annual).
2 superinvestors own EVH
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| Glenn Welling Engaged Capital | 5,563,912 | $13M | 4.18% | ▲ +24.2% |
| Lee Ainslie Maverick Capital | 2,572,763 | $6M | 0.07% | 0.0% |